Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

CANCER:

Squamous Cell Skin Cancer

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related cancers:

‹

Skin Cancer (1090)

Bowens Disease (2)

Skin Cancer (1090)

Bowens Disease (2)

›

No biomarker	Squamous Cell Skin Cancer	No biomarker	Squamous Cell Skin Cancer	pembrolizumab Sensitive: A1 - Approval pembrolizumab Sensitive : A1	pembrolizumab Sensitive: A1 - Approval pembrolizumab Sensitive : A1
No biomarker	Squamous Cell Skin Cancer	No biomarker	Squamous Cell Skin Cancer	cemiplimab-rwlc Sensitive: A1 - Approval cemiplimab-rwlc Sensitive : A1	cemiplimab-rwlc Sensitive: A1 - Approval cemiplimab-rwlc Sensitive : A1
No biomarker	Squamous Cell Skin Cancer	No biomarker	Squamous Cell Skin Cancer	cosibelimab-ipdl Sensitive: A1 - Approval cosibelimab-ipdl Sensitive : A1	cosibelimab-ipdl Sensitive: A1 - Approval cosibelimab-ipdl Sensitive : A1
No biomarker	Squamous Cell Skin Cancer	No biomarker	Squamous Cell Skin Cancer	celecoxib Resistant: A2 - Guideline celecoxib Resistant : A2	celecoxib Resistant: A2 - Guideline celecoxib Resistant : A2
No biomarker	Bowens Disease	No biomarker	Bowens Disease	imiquimod Sensitive: A2 - Guideline imiquimod Sensitive : A2	imiquimod Sensitive: A2 - Guideline imiquimod Sensitive : A2
No biomarker	Bowens Disease	No biomarker	Bowens Disease	5-fluorouracil Sensitive: A2 - Guideline 5-fluorouracil Sensitive : A2	5-fluorouracil Sensitive: A2 - Guideline 5-fluorouracil Sensitive : A2
No biomarker	Squamous Cell Skin Cancer	No biomarker	Squamous Cell Skin Cancer	carboplatin + paclitaxel Sensitive: A2 - Guideline carboplatin + paclitaxel Sensitive : A2	carboplatin + paclitaxel Sensitive: A2 - Guideline carboplatin + paclitaxel Sensitive : A2
No biomarker	Squamous Cell Skin Cancer	No biomarker	Squamous Cell Skin Cancer	carboplatin Sensitive: A2 - Guideline carboplatin Sensitive : A2	carboplatin Sensitive: A2 - Guideline carboplatin Sensitive : A2
No biomarker	Squamous Cell Skin Cancer	No biomarker	Squamous Cell Skin Cancer	cisplatin + 5-fluorouracil Sensitive: A2 - Guideline cisplatin + 5-fluorouracil Sensitive : A2	cisplatin + 5-fluorouracil Sensitive: A2 - Guideline cisplatin + 5-fluorouracil Sensitive : A2
No biomarker	Squamous Cell Skin Cancer	No biomarker	Squamous Cell Skin Cancer	cisplatin Sensitive: A2 - Guideline cisplatin Sensitive : A2	cisplatin Sensitive: A2 - Guideline cisplatin Sensitive : A2
No biomarker	Squamous Cell Skin Cancer	No biomarker	Squamous Cell Skin Cancer	capecitabine Sensitive: A2 - Guideline capecitabine Sensitive : A2	capecitabine Sensitive: A2 - Guideline capecitabine Sensitive : A2
No biomarker	Squamous Cell Skin Cancer	No biomarker	Squamous Cell Skin Cancer	cetuximab Sensitive: A2 - Guideline cetuximab Sensitive : A2	cetuximab Sensitive: A2 - Guideline cetuximab Sensitive : A2